前后比较

前后比较前后比较
  1. pH值治疗前后比较无显著性差异(P>0.05)。

    The saliva pH value was not different comparing before and after treatment .

  2. 各项症状治疗前后比较,有统计学意义(p0.05)。

    The symptoms before and after treatment , there are statistically significant ( p0.05 ) .

  3. RBC、HB治疗前后比较,P>0.05,差别无显著。

    Comparision of RBC before and after treatment , P0.05 , no significant difference .

  4. 安全性判定:安全性指标治疗前后比较无显著差异(P0.05),表明自拟通络逐瘀颗粒对各项安全指标无影响。

    Security Decision : The safety index was no significant difference before and after the treatment .

  5. 3胃镜、病理、HP检查的疗效比较:其自身治疗前后比较均有显著的差异(P<0.05);而治疗组与对照组治疗后比较,均无显著的差异(P>0.05)。

    After treatment the comparison of two groups have no differences ( P > 0.05 ) .

  6. 结果:两组回声灰阶(LEVEL)及透声像素(MAX)治疗前后比较均有显著差异(P<0.01)。

    Results : Both differences of Level and Max before and after treatment in two groups were signifieant ( P < 0.01 ) .

  7. 血清SOD活性和VE含量均降低,P<0.001;透析前后比较LPO降低明显。

    Both serum SOD activity and VE content significantly reduced ( P < 0.001 ) .

  8. 血清E2、FSH治疗前后比较,无统计学意义(P0.05)。

    E2 , FSH therapy before and after comparison , no statistically significant ( P0.05 ) .

  9. 结果吸附透析组患者治疗后皮肤瘙痒缓解率为85%,治疗前后比较有显著性差异(P<0.01)。

    Results In HPHD group , the remission rate of uraemia pruritus was 85 % ( 12 / 15 ), and there was a significant diffierence ( P < 0.01 ) .

  10. 对照组治疗前后比较,差异亦有统计学意义(P0.01)。

    Comparison between the groups before and after treatment , the difference had statistical significance ( P0.01 ) .

  11. 结果:1.实验组针刺前后比较差异显著,具有统计学意义(P0.05)。

    Results : The experimental group has significant differences before and after treatment . The difference has statistical significance ( P0.05 ) .

  12. 三组治疗自身前后比较Em、FD均有统计学意义(p0.05)。

    Three groups before and after treatment itself more Em , FD are statistically significant ( p0.05 ) .

  13. 其结果:①两组一疗程治疗前后比较,快速收缩力和持续收缩力有明显提高,差异显著(P0.01)。

    Both the rapid and the sustained contractility was significantly improved after a course of either treatment ( P0.01 ) .

  14. 一年内住院率:两组患者治疗前后比较,具有统计学意义P0.05,疗效显著,且治疗组优于对照组。

    Rate of hospitalization within one year : two groups of patients before and after treatment , with statistical significance P0.05 , significant effect .

  15. 目的研究淋巴结转移瘤与肌肉CT灌注值的差异和相关性,并进行淋巴结转移瘤治疗前后比较。

    Objective To study the difference and relativity of CT perfusion value between metastatic lymph nodes and muscle , and to find out whether differentiation the malignant nodal after therapy was possible .

  16. 与治疗前比较,B+F组在治疗8周后夜间症状评分明显下降(P0.05),而DoubleB组治疗前后比较差异无统计学意义(P0.05);

    Nocturnal symptom scores were significantly reduced in group B + F ( P 0.05 ) but not in group double B ( P 0.05 ) when compared to pre-treatment .

  17. 训练前后比较差异有极显著性(P0.01)。结论:运动功能康复护理能提高脑卒中偏瘫病人的肢体运动功能和明显改善患者的生活质量。

    Conclusion : The functional recovery nursing can evidently improve the movement function and make the life better of the stroke hemiplegic patients .

  18. 观察组的外周血嗜酸性细胞(EC)计数显著改善,自身前后比较,均P<0.05。

    The amount of peripheral blood acidophil in treatment group was obviously improved that the result was different ( P < 0.05 ) .

  19. 两组患者各自治疗前后比较,P0.05,治疗后优于治疗前,表明两组对痛风性关节炎都是有效的。

    Two groups of patients around respective treatment comparison ( p0.05 ), after the treatment , good before treatment indicated that two groups are effective to this sickness .

  20. 对照组实验前后比较,各分量表分、总量表分及记忆商数的差别无统计学意义(P0.05)。

    In the control group , no significant differences were observed in the subscales points , total points and MQ before and after the trail ( P0.05 ) .

  21. PCOS患者的BMI、WHR均较治疗前减少,前后比较差异有极显著性(P0.01)。

    The BMI and WHR post-treatment in PCOS patients reduce more significantly ( P0.01 ) compared with those prior treatment .

  22. 治疗组单项症状胃脘痛、腹胀、嗳气泛酸缓解较明显,治疗前后比较P<0.01~.P<0.001,并能明显降低胃液胆汁酸浓度(P<0.05)。

    Li Qi He Wei syrup could mitigate the symptoms of stomachache , gastric stuffiness and discomfort , belching and acid regurgitation , there was significant difference between before and after treatment ( P < 0.01-P < 0.001 ) .

  23. [结果]治疗前后比较,晨僵时间、关节疼痛数、关节肿胀数和ESR、CRP均有显著改善(P<0.01或P<0.05);

    [ Results ] After treatment , clinical symptoms and ESR and CRP were significantly improved ( P < 0.01 or P < 0.05 );

  24. 两组治疗前后比较有显著差异,P<0.01,而PaCO2、pH两组治疗前后相比无显著差异,P>0.05。

    The two groups had marked difference , P < 0.01 , but no clear difference in PaCO 2 , pH , P > 0.05 . Conclusion : HFJV with naloxone is very effective in treating the disease .

  25. 两组治疗后E2、P均有所降低,且治疗前后比较均有高度显著性差异(P0.05);但两组间比较差异均无显著性(P0.05)。

    Before and after treatment E2 , P were decreased , there were significant differences ( P0.05 ); but there was no difference between the two groups was significant ( P0.05 ) .

  26. 服药前后比较,苯妥英锌使大鼠血清HDL-C和HDL-C/TC分别上升8%和17%(p<0.05),(LDL+VLDL)-C下降34%(p<0.01);

    Phenytoin zinc could cause HDL-C and HDL-C / TC to increase by 8 % and 17 % . respectively ,( LDL + VLDL ) - C to decrease by 34 % ;

  27. 对照组治疗前后比较PS评分有下降,但差异无显著性,P>0.05,临床表现有改善,但不明显。

    In the control group , Ps scores decreased after treatment , but there were no significant differences , P > 0 . 05 , the clinical manifestations improved little .

  28. 肺功能检测指标:两组患者治疗前后比较,具有统计学意义P0.05,疗效显著,且FEV1/预%优于FEVl/FVC%,治疗组优于对照组。

    And the treatment group than the control group . 4 . Pulmonary function testing indicators : two groups of patients before and after treatment , with statistical significance P0.05 , significant effect .

  29. 本组治疗前后比较有极显著差异(P0.01),治疗组与对照组比较也有显著性差异(P0.05)。

    The treatment is in front and back the oneself contrast have to show difference ( P0.01 ), treatment set and matched control to more also have the difference . ( P0.05 ) .

  30. 治疗前后比较,B组较A组患者心率减慢,QT离散度(QTd)降低,LVEF明显增加,室性心律失常得到更好控制,心功能明显改善。

    After treatment , B group compared with A group , heart rate and QTd reduced , left ventricular eject fraction ( LVEF ) increased , ventricular arrhythmias well-controlled .